

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding the biology of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-406/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-406" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding the biology of marginal zone lymphoma" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding the biology of marginal zone lymphoma.">
            <meta name="og:description" content="Read the latest article version by Francesco Bertoni, Davide Rossi, Emanuele Zucca, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15029">
            <meta name="article-id" content="13826">
            <meta name="dc.title" content="Recent advances in understanding the biology of marginal zone lymphoma">
            <meta name="dc.description" content="There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also present specific alterations that can be used for their differential diagnosis. Although trisomies of chromosomes 3 and 18, deletions at 6q23, deregulation of nuclear factor kappa B, and chromatin remodeling genes are frequent events in all of them, the three MZLs differ in the presence of recurrent translocations, mutations affecting the NOTCH pathway, and the transcription factor Kruppel like factor 2 ( KLF2) or the receptor-type protein tyrosine phosphatase delta ( PTPRD ). Since a better understanding of the molecular events underlying each subtype may have practical relevance, this review summarizes the most recent and main advances in our understanding of the genetics and biology of MZLs.">
            <meta name="dc.subject" content="marginal zone lymphoma, genetics and biology of MZLs, extranodal MZL of MALT type, splenic MZL, nodal MZL">
            <meta name="dc.creator" content="Bertoni, Francesco">
            <meta name="dc.creator" content="Rossi, Davide">
            <meta name="dc.creator" content="Zucca, Emanuele">
            <meta name="dc.date" content="2018/03/28">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.13826.1">
            <meta name="dc.source" content="F1000Research 2018 7:406">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="marginal zone lymphoma">
            <meta name="prism.keyword" content="genetics and biology of MZLs">
            <meta name="prism.keyword" content="extranodal MZL of MALT type">
            <meta name="prism.keyword" content="splenic MZL">
            <meta name="prism.keyword" content="nodal MZL">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/03/28">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="406">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.13826.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-406">
            <meta name="citation_title" content="Recent advances in understanding the biology of marginal zone lymphoma">
            <meta name="citation_abstract" content="There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also present specific alterations that can be used for their differential diagnosis. Although trisomies of chromosomes 3 and 18, deletions at 6q23, deregulation of nuclear factor kappa B, and chromatin remodeling genes are frequent events in all of them, the three MZLs differ in the presence of recurrent translocations, mutations affecting the NOTCH pathway, and the transcription factor Kruppel like factor 2 ( KLF2) or the receptor-type protein tyrosine phosphatase delta ( PTPRD ). Since a better understanding of the molecular events underlying each subtype may have practical relevance, this review summarizes the most recent and main advances in our understanding of the genetics and biology of MZLs.">
            <meta name="citation_description" content="There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also present specific alterations that can be used for their differential diagnosis. Although trisomies of chromosomes 3 and 18, deletions at 6q23, deregulation of nuclear factor kappa B, and chromatin remodeling genes are frequent events in all of them, the three MZLs differ in the presence of recurrent translocations, mutations affecting the NOTCH pathway, and the transcription factor Kruppel like factor 2 ( KLF2) or the receptor-type protein tyrosine phosphatase delta ( PTPRD ). Since a better understanding of the molecular events underlying each subtype may have practical relevance, this review summarizes the most recent and main advances in our understanding of the genetics and biology of MZLs.">
            <meta name="citation_keywords" content="marginal zone lymphoma, genetics and biology of MZLs, extranodal MZL of MALT type, splenic MZL, nodal MZL">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Francesco Bertoni">
            <meta name="citation_author_institution" content="Universit&agrave; della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland">
            <meta name="citation_author_institution" content="Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland">
            <meta name="citation_author" content="Davide Rossi">
            <meta name="citation_author_institution" content="Universit&agrave; della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland">
            <meta name="citation_author_institution" content="Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland">
            <meta name="citation_author" content="Emanuele Zucca">
            <meta name="citation_author_institution" content="Universit&agrave; della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland">
            <meta name="citation_author_institution" content="Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland">
            <meta name="citation_publication_date" content="2018/03/28">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="406">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.13826.1">
            <meta name="citation_firstpage" content="406">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-406/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-406.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15029 /> <input type=hidden id=articleId name=articleId value=13826 /> <input type=hidden id=xmlUrl value="/articles/7-406/v1/xml"/> <input type=hidden id=xmlFileName value="-7-406-v1.xml"> <input type=hidden id=article_uuid value=8d302fa9-aa7f-443e-9cd3-1f97e800d9ae /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding the biology of marginal zone lymphoma"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.13826.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.13826.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-406"
  },
  "headline": "Recent advances in understanding the biology of marginal zone lymphoma",
  "datePublished": "2018-03-28T09:21:59",
  "dateModified": "2018-03-28T09:21:59",
  "author": [
    {
      "@type": "Person",
      "name": "Francesco Bertoni"
    },    {
      "@type": "Person",
      "name": "Davide Rossi"
    },    {
      "@type": "Person",
      "name": "Emanuele Zucca"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also present specific alterations that can be used for their differential diagnosis. Although trisomies of chromosomes 3 and 18, deletions at 6q23, deregulation of nuclear factor kappa B, and chromatin remodeling genes are frequent events in all of them, the three MZLs differ in the presence of recurrent translocations, mutations affecting the NOTCH pathway, and the transcription factor Kruppel like factor 2 (KLF2) or the receptor-type protein tyrosine phosphatase delta (PTPRD). Since a better understanding of the molecular events underlying each subtype may have practical relevance, this review summarizes the most recent and main advances in our understanding of the genetics and biology of MZLs."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-406",
            "name": "Recent advances in understanding the biology of marginal zone lymphoma"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding the biology of marginal zone lymphoma </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15029 data-id=13826 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13826.1" data-recommended="" data-doi="10.12688/f1000research.13826.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-406/v1/pdf?article_uuid=8d302fa9-aa7f-443e-9cd3-1f97e800d9ae" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-13826-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-13826-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-13826-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Bertoni F, Rossi D and Zucca E. Recent advances in understanding the biology of marginal zone lymphoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):406 (<a class=new-orange href="https://doi.org/10.12688/f1000research.13826.1" target=_blank>https://doi.org/10.12688/f1000research.13826.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-13826-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=13826 id=track-article-signin-13826 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13826?target=/articles/7-406">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15029 /> <input name=articleId type=hidden value=13826 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding the biology of marginal zone lymphoma</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Francesco Bertoni<sup>1,2</sup><sup>*</sup>,&nbsp;</span><span class="">Davide Rossi<sup>1,2</sup><sup>*</sup>,&nbsp;</span><span class=""><a href="mailto:ielsg@eoc.ch" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Emanuele Zucca</span></a><a href="https://orcid.org/0000-0002-5522-6109" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5522-6109</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Francesco Bertoni<sup>1,2</sup><sup>*</sup>,&nbsp;</span><span class="">Davide Rossi<sup>1,2</sup><sup>*</sup>,&nbsp;</span><span class=""><a href="mailto:ielsg@eoc.ch" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Emanuele Zucca</span></a><a href="http://orcid.org/0000-0002-5522-6109" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5522-6109</div><sup>1,2</sup></span></div> </div> <div class="authors extra-info"> <sup>*</sup> Equal contributors </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 28 Mar 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.13826.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Universit&agrave; della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland<br/> <sup>2</sup> Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland<br/> <p> <div class=margin-bottom> Francesco Bertoni <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Davide Rossi <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Emanuele Zucca <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=32077-32181></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=32074-32182></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> There are three different marginal zone lymphomas (MZLs): the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL, and the nodal MZL. The three MZLs share common lesions and deregulated pathways but also present specific alterations that can be used for their differential diagnosis. Although trisomies of chromosomes 3 and 18, deletions at 6q23, deregulation of nuclear factor kappa B, and chromatin remodeling genes are frequent events in all of them, the three MZLs differ in the presence of recurrent translocations, mutations affecting the NOTCH pathway, and the transcription factor Kruppel like factor 2 (<i>KLF2)</i> or the receptor-type protein tyrosine phosphatase delta (<i>PTPRD</i>). Since a better understanding of the molecular events underlying each subtype may have practical relevance, this review summarizes the most recent and main advances in our understanding of the genetics and biology of MZLs. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> marginal zone lymphoma, genetics and biology of MZLs, extranodal MZL of MALT type, splenic MZL, nodal MZL </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Emanuele Zucca (<a href="mailto:ielsg@eoc.ch">ielsg@eoc.ch</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Emanuele Zucca </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Bertoni F <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Bertoni F, Rossi D and Zucca E. Recent advances in understanding the biology of marginal zone lymphoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):406 (<a href="https://doi.org/10.12688/f1000research.13826.1" target=_blank>https://doi.org/10.12688/f1000research.13826.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 28 Mar 2018, <b>7</b>(F1000 Faculty Rev):406 (<a href="https://doi.org/10.12688/f1000research.13826.1" target=_blank>https://doi.org/10.12688/f1000research.13826.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 28 Mar 2018, <b>7</b>(F1000 Faculty Rev):406 (<a href="https://doi.org/10.12688/f1000research.13826.1" target=_blank>https://doi.org/10.12688/f1000research.13826.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e202>Introduction</h2><p class="" id=d52903e205>In the World Health Organization classification, there are three different marginal zone lymphoma (MZL) entities with specific diagnostic criteria, behavior, and therapeutic implications: the extranodal MZL of mucosa-associated lymphoid tissue (MALT) type (MALT lymphoma), the splenic MZL (SMZL), and the nodal MZL (NMZL)<sup><a href="#ref-1">1</a></sup>. MALT lymphoma is the commonest MZL type, accounting for 5 to 8% of all B-cell lymphomas<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Their differential diagnosis is not straightforward in the non-rare cases presenting with disseminated disease involving lymph nodes, spleen, peripheral blood, bone marrow, or other extranodal sites. A better understanding of the molecular events underlying each subtype may have practical relevance.</p><p class="" id=d52903e219>MZLs are believed to derive from B cells of the “marginal zone”, the external part of the secondary lymphoid follicles. The marginal zone is more evident in the lymphatic tissues continuously exposed to external antigens, such as the mesenteric lymph nodes, the MALT, and the spleen. Marginal zone B cells act as innate-like lymphocytes able to mount rapid antibody responses to both T cell–dependent and T cell–independent antigens, mostly the latter<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d52903e226>The three MZLs clearly share common lesions and deregulated pathways, but they also present specific alterations that can be used for their differential diagnosis<sup><a href="#ref-5">5</a>–<a href="#ref-24">24</a></sup> (<a href="#f1">Figure 1</a>). Trisomies of chromosomes 3 and 18 and deletions at 6q23 are frequent events in all MZLs, as well as somatic mutations of genes coding for proteins involved in chromatin remodeling<sup><a href="#ref-5">5</a>–<a href="#ref-7">7</a>,<a href="#ref-25">25</a>–<a href="#ref-28">28</a></sup>. The activation of the nuclear factor kappa B (NF-κB) pathway is also common to all three entities, generally via somatic mutations or deletions (or both) of <i>TNFAIP3</i> (A20) at 6q23<sup><a href="#ref-5">5</a>–<a href="#ref-7">7</a>,<a href="#ref-25">25</a>–<a href="#ref-27">27</a>,<a href="#ref-29">29</a>–<a href="#ref-33">33</a></sup>. Mutations affecting the NOTCH pathway and the transcription factor <i>KLF2</i> are present in both SMZL and NMZL<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Whereas SMZL is specifically characterized by deletions of chromosome 7q, NMZL shows inactivation of <i>PTPRD</i> and a much higher prevalence of mutations affecting <i>KMT2D</i> (MLL2)<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a>,<a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. Unlike the vast majority of other B-cell lymphomas, SMZL and NMZL do not present specific recurrent chromosomal translocations, while these are detected in MALT lymphomas, in which at least three of them activate the NF-κB pathway<sup><a href="#ref-8">8</a>–<a href="#ref-14">14</a>,<a href="#ref-16">16</a>,<a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup> (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/15029/5b977775-94fe-43a4-9fd0-d937818e4efd_figure1.gif"><img alt="5b977775-94fe-43a4-9fd0-d937818e4efd_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/15029/5b977775-94fe-43a4-9fd0-d937818e4efd_figure1.gif"></a><div class=caption><h3>Figure 1. Summary of the main genetic and biologic features characterizing marginal zone lymphomas.</h3><p id=d52903e334>^Depending on the anatomical site. BCR, B-cell receptor; IGHV, immunoglobulin heavy variable; MALT, mucosa-associated lymphoid tissue; NF-κB, nuclear factor kappa B; NMZL, nodal marginal zone lymphoma; SMZL, splenic marginal zone lymphoma; TLR, Toll-like receptor.</p></div></div><p class="" id=d52903e342>We will now highlight the most recent and main advances in our understanding of the genetics and biology of MZLs.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e348>NF-κB signaling</h2><p class="" id=d52903e351>Active NF-κB signaling is necessary for the generation and maintenance of normal marginal zone B cells and this requires weak B-cell receptor (BCR) signaling (for example, started by auto-antigens and leading to canonical NF-κB pathway activation) or CD40 signaling, activating the non-canonical NF-κB pathway<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>. Following BCR engagement, Src family kinases phosphorylate the cytoplasmic ITAM portions of CD79A and CD79B<sup><a href="#ref-38">38</a>–<a href="#ref-45">45</a></sup>. The latter bind the tyrosine kinase SYK and start a signaling cascade that, via the Bruton’s tyrosine kinase (BTK), results in phosphorylation and activation of CARD11. CARD11, BCL10, and MALT1 form the CBM signaling complex linking BCR signaling to the canonical NF-κB pathway. Upon phosphorylation, CARD11 acquires an open conformation, allowing the recruitment of CARD11 to MALT1 and BCL10 into the CBM complex and activate the IKBKB kinase. IKBKB phosphorylates the IκBα inhibitor molecule, causing its proteasome-mediated degradation. Finally, the NF-κB complexes (mainly p50/RelA and p50/c-Rel dimers) can enter the nucleus and act as transcriptional factors. TNFAIP3 negatively regulates the whole pathway, adding and subtracting ubiquitin moieties to different NF-κB signaling pathways. Binding of CD40 activates the non-canonical NF-κB pathway. Following disruption of a negative regulatory complex comprising TRAF3/MAP3K14-TRAF2/BIRC3, the MAP3K14 kinase (also known as NIK) phosphorylates NFKB2 (p100), causing its proteasomal processing and the formation of p52-containing NF-κB dimers. In particular, BIRC3 (cIAP2), owing to its C-terminal RING domain, has ubiquitin ligase (E3) activity<sup><a href="#ref-46">46</a></sup> and leads to BCL10 and MAP3K14 ubiquitination<sup><a href="#ref-46">46</a></sup>. Similarly, TRAF3 induces MAP3K14 degradation by recruiting it to the BIRC3 ubiquitin ligase complex. The p52 protein dimerizes with RelB to translocate into the nucleus, acting as a transcriptional factor.</p><p class="" id=d52903e376>In all of the MZLs, both canonical NF-κB signaling and non-canonical NF-κB signaling are deregulated by genetic events. The most frequent event is the inactivation, by deletions or mutations, of its negative regulator encoded by the <i>TNFAIP3</i> (A20) gene<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a>,<a href="#ref-25">25</a>–<a href="#ref-27">27</a>,<a href="#ref-29">29</a>–<a href="#ref-31">31</a>,<a href="#ref-47">47</a></sup>. Three other NF-κB signaling components—<i>MALT1</i>, <i>BCL10</i>, and <i>BIRC3</i>—are involved in the three most recurrent MALT lymphoma translocations: the t(11;18)(q21;q21), the t(14;18)(q32;q21), and the (1;14)(p22;q32)<sup><a href="#ref-46">46</a>,<a href="#ref-48">48</a></sup>. The t(11;18) translocation creates the BIRC3-MALT1 fusion protein, in which BIRC3 always lacks its RING domain; thus, BIRC3-MALT1 can bind BCL10 through the BIR domains of BIRC3 but no longer ubiquitinates BCL10<sup><a href="#ref-46">46</a></sup>. BIRC3-MALT1 can also mediate the proteolytic cleavage of MAP3K14, thereby triggering the non-canonical NF-κB pathway<sup><a href="#ref-49">49</a></sup>. The t(11;18) is the most frequent chromosomal translocation in MALT lymphomas, detected in 15 to 50% of cases, more commonly in gastric and pulmonary MALT lymphomas<sup><a href="#ref-13">13</a>,<a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>. SMZL and NMZL present recurrent mutations of the <i>BIRC3</i> gene in about 10% and 5% of cases, respectively<sup><a href="#ref-6">6</a>,<a href="#ref-31">31</a>,<a href="#ref-52">52</a></sup>. These mutations disrupt the same RING domain that is removed by the t(11;18) in MALT lymphomas, and the mutated BIRC3 is no longer able to inactivate MAP3K14 via ubiquitination<sup><a href="#ref-31">31</a>,<a href="#ref-53">53</a></sup>. <i>TRAF3</i> is also inactivated in about 5% of SMZL and NMZL cases by mutations leading to the loss of its C-terminal MATH domain necessary for the MAP3K14 docking site and recruitment to BIRC3 degradation<sup><a href="#ref-6">6</a>,<a href="#ref-31">31</a></sup>.</p><p class="" id=d52903e471>The t(14;18) translocation occurs in 15 to 20% of MALT lymphomas, more frequently in non-gastrointestinal sites such as lung and ocular adnexa, and brings the intact <i>MALT1</i> gene under the control of the <i>IGH</i> enhancer, resulting in deregulated expression of <i>MALT1</i> directly contributing to NF-κB activation<sup><a href="#ref-10">10</a>,<a href="#ref-54">54</a></sup>. The t(1;14) translocation and its variant t(1;2)(p22;p12) occur in 1 to 2% of MALT lymphomas<sup><a href="#ref-55">55</a></sup>. Similarly to the t(14;18), the entire coding region of <i>BCL10</i> is moved under the control of the <i>IGH</i> enhancer region (or the <i>IGL</i>k region in the case of a variant translocation) and has a direct effect on the NF-κB signaling<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d52903e508>The important role of BIRC3-MALT1 fusion protein, as well as MALT1 and BCL10 upregulation, in MALT lymphoma is further underlined by mouse models with development of MALT lymphomas and DLBCL in <i>MALT1</i> gene transgenic mice<sup><a href="#ref-57">57</a></sup>, expansion of marginal zone cells in <i>BIRC3</i>-<i>MALT1</i><sup><a href="#ref-18">18</a>,<a href="#ref-35">35</a>, </sup>and BCL10 transgenic mice<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d52903e536>In SMZL and NMZL, NF-κB signaling is also sustained by mutations occurring in genes coding members of upstream pathways, such as Toll-like receptor (TLR) and BCR signaling. MYD88 is an adaptor protein necessary for propagating the TLR downstream signal. MYD88 has a modular structure with an N-terminus death domain (DD), an intermediate linker domain (ID), and a C-terminus TIR domain. The DD allows the creation of a multimeric complex, via the oligomerization and interaction with the serine-threonine kinases IRAK1–4, which activate the NF-κB. <i>MYD88</i> is affected by somatic mutations in 15% of SMZLs and 10% of NMZLs and MALT lymphomas. <i>MYD88</i> mutations affect a conserved beta-beta loop of the protein TIR domain<sup><a href="#ref-26">26</a>,<a href="#ref-33">33</a>,<a href="#ref-59">59</a>–<a href="#ref-69">69</a></sup> and lead to spontaneous and uncontrolled MYD88/IRAK complex formation<sup><a href="#ref-59">59</a></sup>. Components of the BCR pathway are also mutated, but almost exclusively in the SMZL and NMZL<sup><a href="#ref-6">6</a>,<a href="#ref-25">25</a>–<a href="#ref-27">27</a>,<a href="#ref-32">32</a>,<a href="#ref-33">33</a>,<a href="#ref-52">52</a>,<a href="#ref-70">70</a></sup>, including <i>CARD11</i>, which links the BCR to NF-κB, in 5 to 10% of cases<sup><a href="#ref-6">6</a>,<a href="#ref-25">25</a>–<a href="#ref-27">27</a>,<a href="#ref-31">31</a>–<a href="#ref-33">33</a>,<a href="#ref-52">52</a>,<a href="#ref-60">60</a>,<a href="#ref-70">70</a></sup>. CARD11 mutations cause spontaneous protein multimerization and association with CBM complex components (for example, BCL10) with IKKβ kinase-mediated NF-κB activation<sup><a href="#ref-71">71</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e622>NOTCH signaling</h2><p class="" id=d52903e625>Similarly to NF-κB signaling, NOTCH activation is important for marginal zone differentiation and homing of B cells to the splenic marginal zone<sup><a href="#ref-72">72</a>–<a href="#ref-74">74</a></sup>. The <i>NOTCH2</i> gene is mutated in 10 to 25% of SMZLs, in about 25% of NMZLs, and in less than 5% of MALT lymphomas<sup><a href="#ref-6">6</a>,<a href="#ref-32">32</a>,<a href="#ref-33">33</a>,<a href="#ref-52">52</a>,<a href="#ref-68">68</a>,<a href="#ref-75">75</a>,<a href="#ref-76">76</a></sup>. <i>NOTCH1</i> is also mutated in about 5% of SMZLs but not at all or at a much lower frequency in NMZL and MALT lymphomas<sup><a href="#ref-6">6</a>,<a href="#ref-77">77</a></sup>. Negative regulators of NOTCH signaling (such as <i>SPEN</i>, <i>DTX1</i>, and <i>MAML2</i>) are also mutated, though at lower frequency, bringing NOTCH activation by genetic events to 40% of SMZLs and NMZLs<sup><a href="#ref-6">6</a>,<a href="#ref-32">32</a>,<a href="#ref-52">52</a></sup>. NOTCH2 and NOTCH1 are heterodimeric transmembrane proteins that, after binding with their ligands, undergo a cleavage of their intracellular portions, which, once in the nucleus, regulate gene expression via binding with transcriptional co-factors<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>. Importantly, <i>NOTCH1</i> and <i>NOTCH2</i> mutations cluster in the C-terminal PEST domain and cause a protein truncation with loss of the region necessary for inactivation via proteasomal degradation. Thus, mutations are believed to enhance the stability of the active NOTCH intracellular domains (NICDs) once it has been triggered by microenvironmental interactions<sup><a href="#ref-80">80</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e712>KLF2</h2><p class="" id=d52903e715>Inactivating mutations in the <i>KLF2</i> gene are very frequent in SMZL (20–40%) and NMZL (20% of cases)<sup><a href="#ref-52">52</a>,<a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>. <i>KLF2</i> is a transcription factor, and mice with a B cell–specific deletion of KLF2 have an increased number of splenic marginal zone B cells<sup><a href="#ref-83">83</a></sup>. In lymphoma cells, mutated KLF2 delocalizes from the nucleus into the cytoplasm and is not able to inhibit the NF-κB signaling activated by upstream pathways, including the BCR and TLR pathways<sup><a href="#ref-82">82</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e745>PTPRD</h2><p class="" id=d52903e748>PTPRD is a receptor-type protein tyrosine phosphatase expressed in normal germinal center B cells and, at lower levels, in marginal zone B cells<sup><a href="#ref-52">52</a></sup>. Almost exclusively in NMZL, <i>PTPRD</i> is inactivated by mutations or deletions in about 20% of cases<sup><a href="#ref-52">52</a></sup>. <i>PTPRD</i> regulates many biologic pathways, and NMZL cases with mutated PTPRD appear to have an increased cell proliferation, indicating an involvement of PTPRD in cell proliferation<sup><a href="#ref-52">52</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e773>Chromatin remodeling and epigenome regulation</h2><p class="" id=d52903e776>As a whole, mutations in genes coding for epigenetic regulators are found in about 40% of MZLs. Although their precise consequences in MZL cells are still unknown, mutations in genes such as <i>KMT2D</i> (MLL2), <i>SIN3A</i>, <i>ARID1A</i>, <i>EP300</i>, C<i>REBBP</i>, and <i>TBL1XR1</i> highlight a deregulation of the epigenome in all three MZLs<sup><a href="#ref-6">6</a>,<a href="#ref-26">26</a>,<a href="#ref-33">33</a>,<a href="#ref-52">52</a>,<a href="#ref-68">68</a>,<a href="#ref-76">76</a>,<a href="#ref-84">84</a></sup>. The importance of epigenetic changes is also underlined by methylation changes described in SMZL, which associate with silencing of different tumor suppressor genes and over-expression of genes involved in BCR/PI3K/AKT/NF-κB signaling, PRC2-complex (<i>EZH2</i>, <i>EED</i>, and <i>SUZ12</i>), and <i>MYC</i> and <i>IRF4</i> targets. Clinically, epigenetic changes in SMZL associate with inferior outcome and risk of transformation to a diffuse large B-cell lymphoma (DLBCL)<sup><a href="#ref-85">85</a></sup>. In MALT lymphomas, promoter methylation seems to increase with a continuum from MALT lymphoma, to MALT lymphoma with large cell component, to DLBCL. Consistently, a series of tumor suppressor genes such as <i>CDKN2A</i>, <i>DAPK1</i>, <i>CDH1</i>, and <i>TNFAIP3</i> are silenced via promoter methylation in MALT lymphoma progression<sup><a href="#ref-86">86</a>–<a href="#ref-88">88</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e864>Antigen stimulation</h2><p class="" id=d52903e867>There is a lot of evidence supporting the notion that antigen stimulation is important for the development and progression of MZLs. MALT lymphoma arises from B cells within populations of immune cells induced by a chronic inflammation taking place in extranodal sites in organs that are physiologically devoid of germinal centers. The most frequent site of MALT lymphoma is the stomach, where the disease has been very clearly associated with the chronic gastritis induced by <i>Helicobacter pylori</i><sup><a href="#ref-89">89</a></sup>. MALT lymphomas arising in other anatomical sites have also been associated with additional infectious agents, although the etiologic link is not as strong as for the gastric localization and <i>H. pylori</i><sup><a href="#ref-89">89</a></sup>. These include <i>Clamydophila psittaci</i> in orbital adnexa MALT lymphoma<sup><a href="#ref-90">90</a>–<a href="#ref-97">97</a></sup>, <i>Borrelia burgdorferi</i> in cutaneous MALT lymphoma<sup><a href="#ref-98">98</a>–<a href="#ref-100">100</a></sup>, <i>Campylobacter jejuni</i> in immunoproliferative small intestine disease<sup><a href="#ref-101">101</a>,<a href="#ref-102">102</a></sup>, <i>Achromobacter xylosoxidans</i> in pulmonary MALT lymphoma<sup><a href="#ref-103">103</a></sup>, and hepatitis C virus (HCV) in all MZLs<sup><a href="#ref-104">104</a>–<a href="#ref-108">108</a></sup>. Besides infection, chronic inflammations in the context of autoimmune disorders, such as Sjögren syndrome or Hashimoto’s thyroiditis, are strongly associated with the development of MALT lymphomas affecting salivary glands and thyroid, respectively<sup><a href="#ref-109">109</a>–<a href="#ref-117">117</a></sup>. Besides the continuous antigenic stimulation, oncogenic events, such as those presented above, contribute to lymphoma growth and progression up to the development of frank tumor independent of the antigenic drive<sup><a href="#ref-89">89</a></sup>.</p><p class="" id=d52903e939>MZLs present somatically mutated immunoglobulin heavy variable (IGHV) genes in nearly all cases with a pattern of somatic hypermutation and rearrangements indicative of an antigen selection<sup><a href="#ref-118">118</a>–<a href="#ref-125">125</a></sup>. The presence of the so-called ongoing mutations (intraclonal variation) and the biased usage of some IGHV segments indicate that the expansion of lymphoma cells could still be antigen-driven. In MALT lymphomas, there is an apparently biased usage of different IGHV families in cases derived from different anatomical sites or with particular clinical and genetic features: IGHVH1-69 in salivary gland lymphomas, IGHVH3-30 or IGHVH3-23 in gastric MALT lymphomas responsive to <i>H. pylori</i> eradication and without the t(11;18) translocation, IGHVH4-34 in orbital adnexal lymphomas, IGHV3 and IGHV4 families in pulmonary lymphomas, and IGHVH1-69 or IGHVH4-59 in cutaneous lymphomas<sup><a href="#ref-126">126</a></sup>. Similarly, a biased IGHV usage is present in SMZL with a stereotyped BCR in about 10% of cases<sup><a href="#ref-127">127</a></sup> and a biased usage of the <i>IGHV 1-2*04</i> allele in about 30% of cases<sup><a href="#ref-123">123</a>,<a href="#ref-127">127</a>–<a href="#ref-130">130</a></sup> and in NMZL with a biased usage of the <i>IGHV4-34</i> gene in 20 to 30% of cases<sup><a href="#ref-131">131</a>,<a href="#ref-132">132</a></sup>. IGHVH1-69 is also frequently detected in HCV-related MZLs, similarly to what observed in other HCV-related B-cell expansions such as in the monoclonal rheumatoid factor-like IgM component of the type II mixed cryoglobulinemia, and in monoclonal paraproteins from patients with HCV infection<sup><a href="#ref-106">106</a>–<a href="#ref-108">108</a>,<a href="#ref-133">133</a></sup>. Finally, the antibodies expressed by MALT lymphoma and SMZL cells often recognize self-antigens<sup><a href="#ref-134">134</a>–<a href="#ref-136">136</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d52903e1004>Clinical implications</h2><p class="" id=d52903e1007>Molecular lesions may be of help to inform MZL diagnosis, prognosis, and therapeutic targeting. In general, the presence of trisomies of 3 and 18 as single lesions or associated only with TNFAIP3 loss or 7q deletions is highly indicative of MZL more than other small cell lymphomas. The presence of translocations affecting <i>MALT1</i> and <i>BIRC3</i> is basically exclusive to MALT lymphoma, in which they are associated with lower response rate to antibiotics treatment. From a diagnostic standpoint, <i>NOTCH2</i> mutations are highly specific for SMZL and NMZL among mature B-cell tumors, including conditions that look alike, thus representing a biomarker with positive predictive value for non-MALT MZL specification. Within non-MALT MZL, <i>PTPRD</i> mutations are enriched in NMZL and thus may represent a genetic biomarker that, though not highly sensitive, is provided with a positive predictive value for NMZL specification.</p><p class="" id=d52903e1022>From a prognostic standpoint, <i>KLF2</i> mutations and <i>NOTCH2</i> mutations represent promising prognostic biomarkers associated with poor survival and transformation to aggressive lymphoma whose broad application in clinical practice requires the assessment of whether their incorporation into the currently available clinical prognostic models improves risk stratification of patients.</p><p class="" id=d52903e1031>Molecular aspects of MZL point to deregulated cellular programs worth exploring as therapeutic targets. Pharmacologic interference of NOTCH signaling, non-canonical NF-κB signaling, or upstream pathways that are connected to NF-κB, including BCR signaling, are attractive approaches in these lymphomas.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d52903e1 class=n-a></a><h2 class=main-title id=d53294>Competing interests</h2><p class=metadata-entry><a name=d52903e133 class=n-a></a><p id=d52903e134> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d52903e1 class=n-a></a><h2 class=main-title id=d53296>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d52903e1038 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d53735>References</h2><div class="section ref-list"><a name=d52903e1038 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d52903e1045 class=n-a></a>Swerdlow SH, Campo E, Harris NL, <i> et al.</i> editors: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2017; 585. <a target=xrefwindow id=d52903e1050 href="http://publications.iarc.fr/Book-And-Report-Series/Who-Iarc-Classification-Of-Tumours/Who-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d52903e1059 class=n-a></a>A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. <i>Blood.</i> 1997; <b>89</b>(11): 3909–18. <a target=xrefwindow id=d52903e1067 href="http://www.ncbi.nlm.nih.gov/pubmed/9166827">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d52903e1076 class=n-a></a>Olszewski AJ, Castillo JJ: Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. <i>Cancer.</i> 2013; <b>119</b>(3): 629–38. <a target=xrefwindow id=d52903e1084 href="http://www.ncbi.nlm.nih.gov/pubmed/22893605">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1087 href="http://dx.doi.org/10.1002/cncr.27773">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d52903e1096 class=n-a></a>Cerutti A, Cols M, Puga I: Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. <i>Nat Rev Immunol.</i> 2013; <b>13</b>(2): 118–32. <a target=xrefwindow id=d52903e1104 href="http://www.ncbi.nlm.nih.gov/pubmed/23348416">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1107 href="http://dx.doi.org/10.1038/nri3383">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1110 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3652659">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d52903e1119 class=n-a></a>Rinaldi A, Mian M, Chigrinova E, <i> et al.</i>: Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. <i>Blood.</i> 2011; <b>117</b>(5): 1595–604. <a target=xrefwindow id=d52903e1130 href="http://www.ncbi.nlm.nih.gov/pubmed/21115979">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1133 href="http://dx.doi.org/10.1182/blood-2010-01-264275">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d52903e1143 class=n-a></a>Rossi D, Trifonov V, Fangazio M, <i> et al.</i>: The coding genome of splenic marginal zone lymphoma: activation of <i>NOTCH2</i> and other pathways regulating marginal zone development. <i>J Exp Med.</i> 2012; <b>209</b>(9): 1537–51. <a target=xrefwindow id=d52903e1157 href="http://www.ncbi.nlm.nih.gov/pubmed/22891273">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1161 href="http://dx.doi.org/10.1084/jem.20120904">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1164 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3428941">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d52903e1173 class=n-a></a>Spina V, Khiabanian H, Bruscaggin A, <i> et al.</i>: The Coding Genome of Nodal Marginal Zone Lymphoma Reveals Recurrent Molecular Alterations of <i>PTPRD</i> and Other Jak/Stat Signaling Genes. <i>Blood.</i> 2014; <b>124</b>: 705. <a target=xrefwindow id=d52903e1187 href="http://www.bloodjournal.org/content/124/21/705?sso-checked=true">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d52903e1196 class=n-a></a>Dierlamm J, Baens M, Wlodarska I, <i> et al.</i>: The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. <i>Blood.</i> 1999; <b>93</b>(11): 3601–9. <a target=xrefwindow id=d52903e1207 href="http://www.ncbi.nlm.nih.gov/pubmed/10339464">PubMed Abstract </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d52903e1216 class=n-a></a>Willis TG, Jadayel DM, Du MQ, <i> et al.</i>: <i>Bcl10</i> is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. <i>Cell.</i> 1999; <b>96</b>(1): 35–45. <a target=xrefwindow id=d52903e1230 href="http://www.ncbi.nlm.nih.gov/pubmed/9989495">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1234 href="http://dx.doi.org/10.1016/S0092-8674(00)80957-5">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d52903e1243 class=n-a></a>Streubel B, Lamprecht A, Dierlamm J, <i> et al.</i>: T(14;18)(q32;q21) involving <i>IGH</i> and <i>MALT1</i> is a frequent chromosomal aberration in MALT lymphoma. <i>Blood.</i> 2003; <b>101</b>(6): 2335–9. <a target=xrefwindow id=d52903e1261 href="http://www.ncbi.nlm.nih.gov/pubmed/12406890">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1264 href="http://dx.doi.org/10.1182/blood-2002-09-2963">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d52903e1273 class=n-a></a>Streubel B, Vinatzer U, Lamprecht A, <i> et al.</i>: T(3;14)(p14.1;q32) involving <i>IGH</i> and <i>FOXP1</i> is a novel recurrent chromosomal aberration in MALT lymphoma. <i>Leukemia.</i> 2005; <b>19</b>(4): 652–8. <a target=xrefwindow id=d52903e1291 href="http://www.ncbi.nlm.nih.gov/pubmed/15703784">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1294 href="http://dx.doi.org/10.1038/sj.leu.2403644">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d52903e1304 class=n-a></a>Remstein ED, Dogan A, Einerson RR, <i> et al.</i>: The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. <i>Am J Surg Pathol.</i> 2006; <b>30</b>(12): 1546–53. <a target=xrefwindow id=d52903e1315 href="http://www.ncbi.nlm.nih.gov/pubmed/17122510">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1318 href="http://dx.doi.org/10.1097/01.pas.0000213275.60962.2a">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d52903e1327 class=n-a></a>Ye H, Liu H, Attygalle A, <i> et al.</i>: Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of <i>H pylori</i> in gastric MALT lymphoma. <i>Blood.</i> 2003; <b>102</b>(3): 1012–8. <a target=xrefwindow id=d52903e1341 href="http://www.ncbi.nlm.nih.gov/pubmed/12676782">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1345 href="http://dx.doi.org/10.1182/blood-2002-11-3502">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d52903e1354 class=n-a></a>Murga Penas EM, Hinz K, Röser K, <i> et al.</i>: Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving <i>MLT/MALT1</i> in MALT lymphomas. <i>Leukemia.</i> 2003; <b>17</b>(11): 2225–9. <a target=xrefwindow id=d52903e1368 href="http://www.ncbi.nlm.nih.gov/pubmed/12931213">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1372 href="http://dx.doi.org/10.1038/sj.leu.2403122">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d52903e1381 class=n-a></a>Ye H, Liu H, Raderer M, <i> et al.</i>: High incidence of t(11;18)(q21;q21) in <i>Helicobacter pylori</i>-negative gastric MALT lymphoma. <i>Blood.</i> 2003; <b>101</b>(7): 2547–50. <a target=xrefwindow id=d52903e1395 href="http://www.ncbi.nlm.nih.gov/pubmed/12517817">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1399 href="http://dx.doi.org/10.1182/blood-2002-10-3167">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d52903e1408 class=n-a></a>Goatly A, Bacon CM, Nakamura S, <i> et al.</i>: <i>FOXP1</i> abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. <i>Mod Pathol.</i> 2008; <b>21</b>(7): 902–11. <a target=xrefwindow id=d52903e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/18487996">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1426 href="http://dx.doi.org/10.1038/modpathol.2008.74">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d52903e1435 class=n-a></a>Liu H, Ye H, Ruskone-Fourmestraux A, <i> et al.</i>: T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to <i>H. pylori</i> eradication. <i>Gastroenterology.</i> 2002; <b>122</b>(5): 1286–94. <a target=xrefwindow id=d52903e1449 href="http://www.ncbi.nlm.nih.gov/pubmed/11984515">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1453 href="http://dx.doi.org/10.1053/gast.2002.33047">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d52903e1463 class=n-a></a>Sagaert X, de Paepe P, Libbrecht L, <i> et al.</i>: Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. <i>J Clin Oncol.</i> 2006; <b>24</b>(16): 2490–7. <a target=xrefwindow id=d52903e1474 href="http://www.ncbi.nlm.nih.gov/pubmed/16636337">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1477 href="http://dx.doi.org/10.1200/JCO.2006.05.6150">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d52903e1486 class=n-a></a>Haralambieva E, Adam P, Ventura R, <i> et al.</i>: Genetic rearrangement of <i>FOXP1</i> is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. <i>Leukemia.</i> 2006; <b>20</b>(7): 1300–3. <a target=xrefwindow id=d52903e1500 href="http://www.ncbi.nlm.nih.gov/pubmed/16673020">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1504 href="http://dx.doi.org/10.1038/sj.leu.2404244">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d52903e1513 class=n-a></a>Dierlamm J, Pittaluga S, Wlodarska I, <i> et al.</i>: Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. <i>Blood.</i> 1996; <b>87</b>(1): 299–307. <a target=xrefwindow id=d52903e1524 href="http://www.ncbi.nlm.nih.gov/pubmed/8547655">PubMed Abstract </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d52903e1533 class=n-a></a>Kwee I, Rancoita PM, Rinaldi A, <i> et al.</i>: Genomic profiles of MALT lymphomas: variability across anatomical sites. <i>Haematologica.</i> 2011; <b>96</b>(7): 1064–6. <a target=xrefwindow id=d52903e1544 href="http://www.ncbi.nlm.nih.gov/pubmed/21459788">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1547 href="http://dx.doi.org/10.3324/haematol.2011.040402">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1551 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3128228">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d52903e1560 class=n-a></a>Baens M, Finalet Ferreiro J, Tousseyn T, <i> et al.</i>: t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates <i>GPR34</i>. <i>Haematologica.</i> 2012; <b>97</b>(2): 184–8. <a target=xrefwindow id=d52903e1574 href="http://www.ncbi.nlm.nih.gov/pubmed/22058210">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1578 href="http://dx.doi.org/10.3324/haematol.2011.052639">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3269475">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d52903e1590 class=n-a></a>Ansell SM, Akasaka T, McPhail E, <i> et al.</i>: t(X;14)(p11;q32) in MALT lymphoma involving <i>GPR34</i> reveals a role for GPR34 in tumor cell growth. <i>Blood.</i> 2012; <b>120</b>(19): 3949–57. <a target=xrefwindow id=d52903e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/22966169">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1608 href="http://dx.doi.org/10.1182/blood-2011-11-389908">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1611 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3496954">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d52903e1621 class=n-a></a>Vinatzer U, Gollinger M, Müllauer L, <i> et al.</i>: Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of <i>ODZ2</i>, <i>JMJD2C</i>, and <i>CNN3</i>. <i>Clin Cancer Res.</i> 2008; <b>14</b>(20): 6426–31. <a target=xrefwindow id=d52903e1642 href="http://www.ncbi.nlm.nih.gov/pubmed/18927281">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1645 href="http://dx.doi.org/10.1158/1078-0432.CCR-08-0702">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d52903e1654 class=n-a></a>Jung H, Yoo HY, Lee SH, <i> et al.</i>: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in <i>TNFAIP3</i> followed by mutations in <i>TBL1XR1</i> and <i>CREBBP</i>. <i>Oncotarget.</i> 2017; <b>8</b>(10): 17038–49. <a target=xrefwindow id=d52903e1675 href="http://www.ncbi.nlm.nih.gov/pubmed/28152507">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1678 href="http://dx.doi.org/10.18632/oncotarget.14928">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1681 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5370020">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d52903e1690 class=n-a></a>Johansson P, Klein-Hitpass L, Grabellus F, <i> et al.</i>: Recurrent mutations in NF-κB pathway components, <i>KMT2D</i>, and <i>NOTCH1/2</i> in ocular adnexal MALT-type marginal zone lymphomas. <i>Oncotarget.</i> 2016; <b>7</b>(38): 62627–39. <a target=xrefwindow id=d52903e1708 href="http://www.ncbi.nlm.nih.gov/pubmed/27566587">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1711 href="http://dx.doi.org/10.18632/oncotarget.11548">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1714 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5308752">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d52903e1723 class=n-a></a>Moody S, Escudero-Ibarz L, Wang M, <i> et al.</i>: Significant association between <i>TNFAIP3</i> inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma. <i>J Pathol.</i> 2017; <b>243</b>(1): 3–8. <a target=xrefwindow id=d52903e1737 href="http://www.ncbi.nlm.nih.gov/pubmed/28682481">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1741 href="http://dx.doi.org/10.1002/path.4933">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d52903e1750 class=n-a></a>Callet-Bauchu E, Baseggio L, Felman P, <i> et al.</i>: Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. <i>Leukemia.</i> 2005; <b>19</b>(10): 1818–23. <a target=xrefwindow id=d52903e1761 href="http://www.ncbi.nlm.nih.gov/pubmed/16094418">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1764 href="http://dx.doi.org/10.1038/sj.leu.2403909">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1159477"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e1773 class=n-a></a>Novak U, Rinaldi A, Kwee I, <i> et al.</i>: The NF-{kappa}B negative regulator <i>TNFAIP3</i> (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. <i>Blood.</i> 2009; <b>113</b>(20): 4918–21. <a target=xrefwindow id=d52903e1787 href="http://www.ncbi.nlm.nih.gov/pubmed/19258598">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1791 href="http://dx.doi.org/10.1182/blood-2008-08-174110">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1794 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2686142">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1159477">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d52903e1808 class=n-a></a>Honma K, Tsuzuki S, Nakagawa M, <i> et al.</i>: <i>TNFAIP3/A20</i> functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. <i>Blood.</i> 2009; <b>114</b>(12): 2467–75. <a target=xrefwindow id=d52903e1822 href="http://www.ncbi.nlm.nih.gov/pubmed/19608751">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1826 href="http://dx.doi.org/10.1182/blood-2008-12-194852">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d52903e1835 class=n-a></a>Rossi D, Deaglio S, Dominguez-Sola D, <i> et al.</i>: Alteration of <i>BIRC3</i> and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. <i>Blood.</i> 2011; <b>118</b>(18): 4930–4. <a target=xrefwindow id=d52903e1849 href="http://www.ncbi.nlm.nih.gov/pubmed/21881048">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1853 href="http://dx.doi.org/10.1182/blood-2011-06-359166">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d52903e1862 class=n-a></a>Kiel MJ, Velusamy T, Betz BL, <i> et al.</i>: Whole-genome sequencing identifies recurrent somatic <i>NOTCH2</i> mutations in splenic marginal zone lymphoma. <i>J Exp Med.</i> 2012; <b>209</b>(9): 1553–65. <a target=xrefwindow id=d52903e1876 href="http://www.ncbi.nlm.nih.gov/pubmed/22891276">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1880 href="http://dx.doi.org/10.1084/jem.20120910">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1883 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3428949">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d52903e1892 class=n-a></a>Parry M, Rose-Zerilli MJ, Ljungström V, <i> et al.</i>: Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. <i>Clin Cancer Res.</i> 2015; <b>21</b>(18): 4174–83. <a target=xrefwindow id=d52903e1903 href="http://www.ncbi.nlm.nih.gov/pubmed/25779943">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1906 href="http://dx.doi.org/10.1158/1078-0432.CCR-14-2759">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1910 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4490180">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d52903e1919 class=n-a></a>Jost PJ, Ruland J: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. <i>Blood.</i> 2007; <b>109</b>(7): 2700–7. <a target=xrefwindow id=d52903e1927 href="http://www.ncbi.nlm.nih.gov/pubmed/17119127">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1930 href="http://dx.doi.org/10.1182/blood-2006-07-025809">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d52903e1939 class=n-a></a>Baens M, Fevery S, Sagaert X, <i> et al.</i>: Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. <i>Cancer Res.</i> 2006; <b>66</b>(10): 5270–7. <a target=xrefwindow id=d52903e1950 href="http://www.ncbi.nlm.nih.gov/pubmed/16707452">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1953 href="http://dx.doi.org/10.1158/0008-5472.CAN-05-4590">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d52903e1963 class=n-a></a>Allman D, Pillai S: Peripheral B cell subsets. <i>Curr Opin Immunol.</i> 2008; <b>20</b>(2): 149–57. <a target=xrefwindow id=d52903e1971 href="http://www.ncbi.nlm.nih.gov/pubmed/18434123">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1974 href="http://dx.doi.org/10.1016/j.coi.2008.03.014">Publisher Full Text </a> | <a target=xrefwindow id=d52903e1977 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2532490">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d52903e1986 class=n-a></a>Spina V, Rossi D: NF-κB deregulation in splenic marginal zone lymphoma. <i>Semin Cancer Biol.</i> 2016; <b>39</b>: 61–7. <a target=xrefwindow id=d52903e1994 href="http://www.ncbi.nlm.nih.gov/pubmed/27503810">PubMed Abstract </a> | <a target=xrefwindow id=d52903e1997 href="http://dx.doi.org/10.1016/j.semcancer.2016.08.002">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d52903e2006 class=n-a></a>Lim KH, Staudt LM: Toll-like receptor signaling. <i>Cold Spring Harb Perspect Biol.</i> 2013; <b>5</b>(1): a011247. <a target=xrefwindow id=d52903e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/23284045">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2017 href="http://dx.doi.org/10.1101/cshperspect.a011247">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3579400">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d52903e2029 class=n-a></a>Staudt LM: Oncogenic activation of NF-kappaB. <i>Cold Spring Harb Perspect Biol.</i> 2010; <b>2</b>(6): a000109. <a target=xrefwindow id=d52903e2037 href="http://www.ncbi.nlm.nih.gov/pubmed/20516126">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2040 href="http://dx.doi.org/10.1101/cshperspect.a000109">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2869521">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d52903e2052 class=n-a></a>Yang Y, Staudt LM: Protein ubiquitination in lymphoid malignancies. <i>Immunol Rev.</i> 2015; <b>263</b>(1): 240–56. <a target=xrefwindow id=d52903e2060 href="http://www.ncbi.nlm.nih.gov/pubmed/25510281">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2063 href="http://dx.doi.org/10.1111/imr.12247">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4269229">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726665278"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2075 class=n-a></a>Pasqualucci L, Zhang B: Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma. <i>Semin Cancer Biol.</i> 2016; <b>39</b>: 26–31. <a target=xrefwindow id=d52903e2083 href="http://www.ncbi.nlm.nih.gov/pubmed/27546290">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2086 href="http://dx.doi.org/10.1016/j.semcancer.2016.08.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726665278">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726402319"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2100 class=n-a></a>Krappmann D, Vincendeau M: Mechanisms of NF-κB deregulation in lymphoid malignancies. <i>Semin Cancer Biol.</i> 2016; <b>39</b>: 3–14. <a target=xrefwindow id=d52903e2108 href="http://www.ncbi.nlm.nih.gov/pubmed/27262792">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2111 href="http://dx.doi.org/10.1016/j.semcancer.2016.05.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726402319">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727236841"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2124 class=n-a></a>Zhang Q, Lenardo MJ, Baltimore D: 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. <i>Cell.</i> 2017; <b>168</b>(1–2): 37–57. <a target=xrefwindow id=d52903e2132 href="http://www.ncbi.nlm.nih.gov/pubmed/28086098">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2135 href="http://dx.doi.org/10.1016/j.cell.2016.12.012">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2138 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5268070">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727236841">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d52903e2151 class=n-a></a>Samelson LE: Immunoreceptor signaling. <i>Cold Spring Harb Perspect Biol.</i> 2011; <b>3</b>(12): pii: a011510. <a target=xrefwindow id=d52903e2159 href="http://www.ncbi.nlm.nih.gov/pubmed/22134888">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2162 href="http://dx.doi.org/10.1101/cshperspect.a011510">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2165 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3225951">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13445989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2174 class=n-a></a>Hailfinger S, Nogai H, Pelzer C, <i> et al.</i>: Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(35): 14596–601. <a target=xrefwindow id=d52903e2185 href="http://www.ncbi.nlm.nih.gov/pubmed/21873235">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2188 href="http://dx.doi.org/10.1073/pnas.1105020108">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2192 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3167514">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13445989">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d52903e2205 class=n-a></a>Hu S, Du MQ, Park SM, <i> et al.</i>: cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. <i>J Clin Invest.</i> 2006; <b>116</b>(1): 174–81. <a target=xrefwindow id=d52903e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/16395405">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2219 href="http://dx.doi.org/10.1172/JCI25641">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2223 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1323253">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d52903e2232 class=n-a></a>Honma K, Tsuzuki S, Nakagawa M, <i> et al.</i>: <i>TNFAIP3</i> is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. <i>Genes Chromosomes Cancer.</i> 2008; <b>47</b>(1): 1–7. <a target=xrefwindow id=d52903e2246 href="http://www.ncbi.nlm.nih.gov/pubmed/17886247">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2250 href="http://dx.doi.org/10.1002/gcc.20499">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d52903e2260 class=n-a></a>Ho L, Davis RE, Conne B, <i> et al.</i>: MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. <i>Blood.</i> 2005; <b>105</b>(7): 2891–9. <a target=xrefwindow id=d52903e2271 href="http://www.ncbi.nlm.nih.gov/pubmed/15598810">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2274 href="http://dx.doi.org/10.1182/blood-2004-06-2297">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8193956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2283 class=n-a></a>Rosebeck S, Madden L, Jin X, <i> et al.</i>: Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. <i>Science.</i> 2011; <b>331</b>(6016): 468–72. <a target=xrefwindow id=d52903e2294 href="http://www.ncbi.nlm.nih.gov/pubmed/21273489">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2297 href="http://dx.doi.org/10.1126/science.1198946">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2301 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3124150">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8193956">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d52903e2314 class=n-a></a>Bertoni F, Coiffier B, Salles G, <i> et al.</i>: MALT lymphomas: pathogenesis can drive treatment. <i>Oncology (Williston Park).</i> 2011; <b>25</b>(12): 1134–42, 1147. <a target=xrefwindow id=d52903e2325 href="http://www.ncbi.nlm.nih.gov/pubmed/22229204">PubMed Abstract </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1020505"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2334 class=n-a></a>Streubel B, Chott A, Huber D, <i> et al.</i>: Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. <i>N Engl J Med.</i> 2004; <b>351</b>(3): 250–9. <a target=xrefwindow id=d52903e2345 href="http://www.ncbi.nlm.nih.gov/pubmed/15254283">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2348 href="http://dx.doi.org/10.1056/NEJMoa033153">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1020505">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d52903e2361 class=n-a></a>Spina V, Khiabanian H, Messina M, <i> et al.</i>: The genetics of nodal marginal zone lymphoma. <i>Blood.</i> 2016; <b>128</b>(10): 1362–73. <a target=xrefwindow id=d52903e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/27335277">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2375 href="http://dx.doi.org/10.1182/blood-2016-02-696757">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2379 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5016706">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718215363"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2388 class=n-a></a>Rahal R, Frick M, Romero R, <i> et al.</i>: Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma. <i>Nat Med.</i> 2014; <b>20</b>(1): 87–92. <a target=xrefwindow id=d52903e2399 href="http://www.ncbi.nlm.nih.gov/pubmed/24362935">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2402 href="http://dx.doi.org/10.1038/nm.3435">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718215363">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d52903e2416 class=n-a></a>Remstein ED, Kurtin PJ, Einerson RR, <i> et al.</i>: Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving <i>API2</i> and <i>MALT1</i> and <i>IGH</i> and <i>MALT1</i>. <i>Leukemia.</i> 2004; <b>18</b>(1): 156–60. <a target=xrefwindow id=d52903e2440 href="http://www.ncbi.nlm.nih.gov/pubmed/14574335">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2443 href="http://dx.doi.org/10.1038/sj.leu.2403185">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d52903e2452 class=n-a></a>Achuthan R, Bell SM, Leek JP, <i> et al.</i>: Novel translocation of the <i>BCL10</i> gene in a case of mucosa associated lymphoid tissue lymphoma. <i>Genes Chromosomes Cancer.</i> 2000; <b>29</b>(4): 347–9. <a target=xrefwindow id=d52903e2466 href="http://www.ncbi.nlm.nih.gov/pubmed/11066079">PubMed Abstract </a> | <a target="xrefwindow" id="d52903e2470" href="http://dx.doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1048&gt;3.0.CO;2-B">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d52903e2479 class=n-a></a>Thome M: CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. <i>Nat Rev Immunol.</i> 2004; <b>4</b>(5): 348–59. <a target=xrefwindow id=d52903e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/15122200">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2490 href="http://dx.doi.org/10.1038/nri1352">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717950674"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2499 class=n-a></a>Vicente-Dueñas C, Fontán L, Gonzalez-Herrero I, <i> et al.</i>: Expression of <i>MALT1</i> oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(26): 10534–9. <a target=xrefwindow id=d52903e2513 href="http://www.ncbi.nlm.nih.gov/pubmed/22689981">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2517 href="http://dx.doi.org/10.1073/pnas.1204127109">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2520 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3387079">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717950674">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d52903e2533 class=n-a></a>Li Z, Wang H, Xue L, <i> et al.</i>: Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. <i>Blood.</i> 2009; <b>114</b>(19): 4158–68. <a target=xrefwindow id=d52903e2544 href="http://www.ncbi.nlm.nih.gov/pubmed/19696203">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2547 href="http://dx.doi.org/10.1182/blood-2008-12-192583">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2551 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2774552">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8044956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2560 class=n-a></a>Ngo VN, Young RM, Schmitz R, <i> et al.</i>: Oncogenically active <i>MYD88</i> mutations in human lymphoma. <i>Nature.</i> 2011; <b>470</b>(7332): 115–9. <a target=xrefwindow id=d52903e2574 href="http://www.ncbi.nlm.nih.gov/pubmed/21179087">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2578 href="http://dx.doi.org/10.1038/nature09671">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5024568">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8044956">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d52903e2595 class=n-a></a>Yan Q, Huang Y, Watkins AJ, <i> et al.</i>: BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. <i>Haematologica.</i> 2012; <b>97</b>(4): 595–8. <a target=xrefwindow id=d52903e2606 href="http://www.ncbi.nlm.nih.gov/pubmed/22102703">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2609 href="http://dx.doi.org/10.3324/haematol.2011.054080">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2613 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3347666">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d52903e2622 class=n-a></a>Gachard N, Parrens M, Soubeyran I, <i> et al.</i>: <i>IGHV</i> gene features and <i>MYD88</i> L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. <i>Leukemia.</i> 2013; <b>27</b>(1): 183–9. <a target=xrefwindow id=d52903e2640 href="http://www.ncbi.nlm.nih.gov/pubmed/22944768">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2643 href="http://dx.doi.org/10.1038/leu.2012.257">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d52903e2652 class=n-a></a>Xu L, Hunter ZR, Yang G, <i> et al.</i>: MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. <i>Blood.</i> 2013; <b>121</b>(11): 2051–8. <a target=xrefwindow id=d52903e2663 href="http://www.ncbi.nlm.nih.gov/pubmed/23321251">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2666 href="http://dx.doi.org/10.1182/blood-2012-09-454355">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2670 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3596964">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d52903e2679 class=n-a></a>Trøen G, Warsame A, Delabie J: CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma. <i>ISRN Oncol.</i> 2013; <b>2013</b>: 252318. <a target=xrefwindow id=d52903e2687 href="http://www.ncbi.nlm.nih.gov/pubmed/23378931">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2690 href="http://dx.doi.org/10.1155/2013/252318">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3556831">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d52903e2702 class=n-a></a>Li Z, Rinaldi A, Cavalli A, <i> et al.</i>: <i>MYD88</i> somatic mutations in MALT lymphomas. <i>Br J Haematol.</i> 2012; <b>158</b>(5): 662–4. <a target=xrefwindow id=d52903e2716 href="http://www.ncbi.nlm.nih.gov/pubmed/22640364">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2720 href="http://dx.doi.org/10.1111/j.1365-2141.2012.09176.x">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d52903e2729 class=n-a></a>Varettoni M, Arcaini L, Zibellini S, <i> et al.</i>: Prevalence and clinical significance of the <i>MYD88</i> (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. <i>Blood.</i> 2013; <b>121</b>(13): 2522–8. <a target=xrefwindow id=d52903e2743 href="http://www.ncbi.nlm.nih.gov/pubmed/23355535">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2747 href="http://dx.doi.org/10.1182/blood-2012-09-457101">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d52903e2757 class=n-a></a>Hamadeh F, MacNamara SP, Aguilera NS, <i> et al.</i>: <i>MYD88 L265P</i> mutation analysis helps define nodal lymphoplasmacytic lymphoma. <i>Mod Pathol.</i> 2015; <b>28</b>(4): 564–74. <a target=xrefwindow id=d52903e2771 href="http://www.ncbi.nlm.nih.gov/pubmed/25216226">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2775 href="http://dx.doi.org/10.1038/modpathol.2014.120">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d52903e2784 class=n-a></a>Martinez-Lopez A, Curiel-Olmo S, Mollejo M, <i> et al.</i>: MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. <i>Am J Surg Pathol.</i> 2015; <b>39</b>(5): 644–51. <a target=xrefwindow id=d52903e2795 href="http://www.ncbi.nlm.nih.gov/pubmed/25723115">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2798 href="http://dx.doi.org/10.1097/PAS.0000000000000411">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d52903e2807 class=n-a></a>Martínez N, Almaraz C, Vaqué JP, <i> et al.</i>: Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. <i>Leukemia.</i> 2014; <b>28</b>(6): 1334–40. <a target=xrefwindow id=d52903e2818 href="http://www.ncbi.nlm.nih.gov/pubmed/24296945">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2821 href="http://dx.doi.org/10.1038/leu.2013.365">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d52903e2830 class=n-a></a>Peveling-Oberhag J, Wolters F, Döring C, <i> et al.</i>: Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations. <i>BMC Cancer.</i> 2015; <b>15</b>: 773. <a target=xrefwindow id=d52903e2841 href="http://www.ncbi.nlm.nih.gov/pubmed/26498442">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2844 href="http://dx.doi.org/10.1186/s12885-015-1766-z">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2848 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4619476">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d52903e2857 class=n-a></a>Yan Q, Wang M, Moody S, <i> et al.</i>: Distinct involvement of NF-κB regulators by somatic mutation in ocular adnexal malt lymphoma. <i>Br J Haematol.</i> 2013; <b>160</b>(6): 851–4. <a target=xrefwindow id=d52903e2868 href="http://www.ncbi.nlm.nih.gov/pubmed/23240725">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2871 href="http://dx.doi.org/10.1111/bjh.12162">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1105279"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e2880 class=n-a></a>Lenz G, Davis RE, Ngo VN, <i> et al.</i>: Oncogenic <i>CARD11</i> mutations in human diffuse large B cell lymphoma. <i>Science.</i> 2008; <b>319</b>(5870): 1676–9. <a target=xrefwindow id=d52903e2894 href="http://www.ncbi.nlm.nih.gov/pubmed/18323416">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2898 href="http://dx.doi.org/10.1126/science.1153629">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1105279">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d52903e2912 class=n-a></a>Descatoire M, Weller S, Irtan S, <i> et al.</i>: Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties. <i>J Exp Med.</i> 2014; <b>211</b>(5): 987–1000. <a target=xrefwindow id=d52903e2923 href="http://www.ncbi.nlm.nih.gov/pubmed/24733829">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2926 href="http://dx.doi.org/10.1084/jem.20132203">Publisher Full Text </a> | <a target=xrefwindow id=d52903e2930 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4010902">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d52903e2939 class=n-a></a>Witt CM, Won WJ, Hurez V, <i> et al.</i>: Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. <i>J Immunol.</i> 2003; <b>171</b>(6): 2783–8. <a target=xrefwindow id=d52903e2950 href="http://www.ncbi.nlm.nih.gov/pubmed/12960298">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2953 href="http://dx.doi.org/10.4049/jimmunol.171.6.2783">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d52903e2962 class=n-a></a>Moran ST, Cariappa A, Liu H, <i> et al.</i>: Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. <i>J Immunol.</i> 2007; <b>179</b>(1): 195–200. <a target=xrefwindow id=d52903e2973 href="http://www.ncbi.nlm.nih.gov/pubmed/17579038">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2976 href="http://dx.doi.org/10.4049/jimmunol.179.1.195">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d52903e2985 class=n-a></a>Bruscaggin A, Monti S, Arcaini L, <i> et al.</i>: Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. <i>Br J Haematol.</i> 2014; <b>167</b>(5): 718–20. <a target=xrefwindow id=d52903e2996 href="http://www.ncbi.nlm.nih.gov/pubmed/25088352">PubMed Abstract </a> | <a target=xrefwindow id=d52903e2999 href="http://dx.doi.org/10.1111/bjh.13052">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d52903e3008 class=n-a></a>Parry M, Rose-Zerilli MJ, Gibson J, <i> et al.</i>: Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. <i>PLoS One.</i> 2013; <b>8</b>(12): e83244. <a target=xrefwindow id=d52903e3019 href="http://www.ncbi.nlm.nih.gov/pubmed/24349473">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3022 href="http://dx.doi.org/10.1371/journal.pone.0083244">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3026 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3862727">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d52903e3035 class=n-a></a>Mensah AA, Rinaldi A, Ponzoni M, <i> et al.</i>: Absence of <i>NOTCH1</i> gene mutations in MALT lymphomas. <i>Br J Haematol.</i> 2012; <b>157</b>(3): 382–4. <a target=xrefwindow id=d52903e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/22171922">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3053 href="http://dx.doi.org/10.1111/j.1365-2141.2011.08980.x">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726632181"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e3063 class=n-a></a>Bray SJ: Notch signalling in context. <i>Nat Rev Mol Cell Biol.</i> 2016; <b>17</b>(11): 722–35. <a target=xrefwindow id=d52903e3071 href="http://www.ncbi.nlm.nih.gov/pubmed/27507209">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3074 href="http://dx.doi.org/10.1038/nrm.2016.94">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726632181">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732108050"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e3087 class=n-a></a>Brzozowa-Zasada M, Piecuch A, Michalski M, <i> et al.</i>: Notch and its oncogenic activity in human malignancies. <i>Eur Surg.</i> 2017; <b>49</b>(5): 199–209. <a target=xrefwindow id=d52903e3098 href="http://www.ncbi.nlm.nih.gov/pubmed/29104587">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3101 href="http://dx.doi.org/10.1007/s10353-017-0491-z">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3105 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5653712">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732108050">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d52903e3118 class=n-a></a>Arruga F, Gizdic B, Serra S, <i> et al.</i>: Functional impact of <i>NOTCH1</i> mutations in chronic lymphocytic leukemia. <i>Leukemia.</i> 2014; <b>28</b>(5): 1060–70. <a target=xrefwindow id=d52903e3132 href="http://www.ncbi.nlm.nih.gov/pubmed/24170027">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3136 href="http://dx.doi.org/10.1038/leu.2013.319">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d52903e3145 class=n-a></a>Piva R, Deaglio S, Famà R, <i> et al.</i>: The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. <i>Leukemia.</i> 2015; <b>29</b>(2): 503–7. <a target=xrefwindow id=d52903e3156 href="http://www.ncbi.nlm.nih.gov/pubmed/25283840">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3159 href="http://dx.doi.org/10.1038/leu.2014.294">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d52903e3168 class=n-a></a>Clipson A, Wang M, de Leval L, <i> et al.</i>: KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. <i>Leukemia.</i> 2015; <b>29</b>(5): 1177–85. <a target=xrefwindow id=d52903e3179 href="http://www.ncbi.nlm.nih.gov/pubmed/25428260">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3182 href="http://dx.doi.org/10.1038/leu.2014.330">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d52903e3191 class=n-a></a>Winkelmann R, Sandrock L, Porstner M, <i> et al.</i>: B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(2): 710–5. <a target=xrefwindow id=d52903e3202 href="http://www.ncbi.nlm.nih.gov/pubmed/21187409">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3205 href="http://dx.doi.org/10.1073/pnas.1012858108">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3209 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3021026">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d52903e3219 class=n-a></a>Cani AK, Soliman M, Hovelson DH, <i> et al.</i>: Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. <i>Mod Pathol.</i> 2016; <b>29</b>(7): 685–97. <a target=xrefwindow id=d52903e3230 href="http://www.ncbi.nlm.nih.gov/pubmed/27102345">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3233 href="http://dx.doi.org/10.1038/modpathol.2016.79">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4925176">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d52903e3246 class=n-a></a>Arribas AJ, Rinaldi A, Mensah AA, <i> et al.</i>: DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. <i>Blood.</i> 2015; <b>125</b>(12): 1922–31. <a target=xrefwindow id=d52903e3257 href="http://www.ncbi.nlm.nih.gov/pubmed/25612624">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3260 href="http://dx.doi.org/10.1182/blood-2014-08-596247">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3264 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4416938">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d52903e3273 class=n-a></a>Arribas AJ, Bertoni F: Methylation patterns in marginal zone lymphoma. <i>Best Pract Res Clin Haematol.</i> 2017; <b>30</b>(1–2): 24–31. <a target=xrefwindow id=d52903e3281 href="http://www.ncbi.nlm.nih.gov/pubmed/28288713">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3284 href="http://dx.doi.org/10.1016/j.beha.2016.09.003">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d52903e3293 class=n-a></a>Kondo T, Oka T, Sato H, <i> et al.</i>: Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma. <i>Int J Oncol.</i> 2009; <b>35</b>(3): 547–57. <a target=xrefwindow id=d52903e3304 href="http://www.ncbi.nlm.nih.gov/pubmed/19639175">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3307 href="http://dx.doi.org/10.3892/ijo_00000366">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d52903e3316 class=n-a></a>Lee MJ, Min BJ, Choung HK, <i> et al.</i>: Genome-wide DNA methylation profiles according to Chlamydophila psittaci infection and the response to doxycycline treatment in ocular adnexal lymphoma. <i>Mol Vis.</i> 2014; <b>20</b>: 1037–47. <a target=xrefwindow id=d52903e3327 href="http://www.ncbi.nlm.nih.gov/pubmed/25053874">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3330 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4105114">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d52903e3339 class=n-a></a>Zucca E, Bertoni F, Vannata B, <i> et al.</i>: Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas. <i>Clin Cancer Res.</i> 2014; <b>20</b>(20): 5207–16. <a target=xrefwindow id=d52903e3350 href="http://www.ncbi.nlm.nih.gov/pubmed/25320370">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3353 href="http://dx.doi.org/10.1158/1078-0432.CCR-14-0496">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d52903e3363 class=n-a></a>Ferreri AJ, Guidoboni M, Ponzoni M, <i> et al.</i>: Evidence for an association between <i>Chlamydia psittaci</i> and ocular adnexal lymphomas. <i>J Natl Cancer Inst.</i> 2004; <b>96</b>(8): 586–94. <a target=xrefwindow id=d52903e3377 href="http://www.ncbi.nlm.nih.gov/pubmed/15100336">PubMed Abstract </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d52903e3386 class=n-a></a>Ferreri AJ, Ponzoni M, Guidoboni M, <i> et al.</i>: Regression of ocular adnexal lymphoma after <i>Chlamydia psittaci</i>-eradicating antibiotic therapy. <i>J Clin Oncol.</i> 2005; <b>23</b>(22): 5067–73. <a target=xrefwindow id=d52903e3400 href="http://www.ncbi.nlm.nih.gov/pubmed/15968003">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3404 href="http://dx.doi.org/10.1200/JCO.2005.07.083">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d52903e3413 class=n-a></a>Vargas RL, Fallone E, Felgar RE, <i> et al.</i>: Is there an association between ocular adnexal lymphoma and infection with <i>Chlamydia psittaci</i>? The University of Rochester experience. <i>Leuk Res.</i> 2006; <b>30</b>(5): 547–51. <a target=xrefwindow id=d52903e3427 href="http://www.ncbi.nlm.nih.gov/pubmed/16246419">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3431 href="http://dx.doi.org/10.1016/j.leukres.2005.09.012">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d52903e3440 class=n-a></a>Chanudet E, Zhou Y, Bacon CM, <i> et al.</i>: <i>Chlamydia psittaci</i> is variably associated with ocular adnexal MALT lymphoma in different geographical regions. <i>J Pathol.</i> 2006; <b>209</b>(3): 344–51. <a target=xrefwindow id=d52903e3454 href="http://www.ncbi.nlm.nih.gov/pubmed/16583361">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3458 href="http://dx.doi.org/10.1002/path.1984">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d52903e3467 class=n-a></a>Daibata M, Nemoto Y, Togitani K, <i> et al.</i>: Absence of <i>Chlamydia psittaci</i> in ocular adnexal lymphoma from Japanese patients. <i>Br J Haematol.</i> 2006; <b>132</b>(5): 651–2. <a target=xrefwindow id=d52903e3481 href="http://www.ncbi.nlm.nih.gov/pubmed/16445841">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3485 href="http://dx.doi.org/10.1111/j.1365-2141.2005.05943.x">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d52903e3494 class=n-a></a>Ferreri AJ, Ponzoni M, Viale E, <i> et al.</i>: Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications. <i>Hematol Oncol.</i> 2006; <b>24</b>(1): 33–7. <a target=xrefwindow id=d52903e3505 href="http://www.ncbi.nlm.nih.gov/pubmed/16385613">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3508 href="http://dx.doi.org/10.1002/hon.768">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d52903e3518 class=n-a></a>Mulder MM, Heddema ER, Pannekoek Y, <i> et al.</i>: No evidence for an association of ocular adnexal lymphoma with <i>Chlamydia psittaci</i> in a cohort of patients from the Netherlands. <i>Leuk Res.</i> 2006; <b>30</b>(10): 1305–7. <a target=xrefwindow id=d52903e3532 href="http://www.ncbi.nlm.nih.gov/pubmed/16420962">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3536 href="http://dx.doi.org/10.1016/j.leukres.2005.12.003">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d52903e3545 class=n-a></a>Gracia E, Froesch P, Mazzucchelli L, <i> et al.</i>: Low prevalence of <i>Chlamydia psittaci</i> in ocular adnexal lymphomas from Cuban patients. <i>Leuk Lymphoma.</i> 2007; <b>48</b>(1): 104–8. <a target=xrefwindow id=d52903e3559 href="http://www.ncbi.nlm.nih.gov/pubmed/17325853">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3563 href="http://dx.doi.org/10.1080/10428190600908174">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d52903e3572 class=n-a></a>Ponzoni M, Ferreri AJ, Mappa S, <i> et al.</i>: Prevalence of <i>Borrelia burgdorferi</i> infection in a series of 98 primary cutaneous lymphomas. <i>Oncologist.</i> 2011; <b>16</b>(11): 1582–8. <a target=xrefwindow id=d52903e3586 href="http://www.ncbi.nlm.nih.gov/pubmed/22071292">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3590 href="http://dx.doi.org/10.1634/theoncologist.2011-0108">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3593 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3233293">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d52903e3602 class=n-a></a>Roggero E, Zucca E, Mainetti C, <i> et al.</i>: Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. <i>Hum Pathol.</i> 2000; <b>31</b>(2): 263–8. <a target=xrefwindow id=d52903e3613 href="http://www.ncbi.nlm.nih.gov/pubmed/10685647">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3616 href="http://dx.doi.org/10.1016/S0046-8177(00)80233-6">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d52903e3625 class=n-a></a>Kütting B, Bonsmann G, Metze D, <i> et al.</i>: Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. <i>J Am Acad Dermatol.</i> 1997; <b>36</b>(2 Pt 2): 311–4. <a target=xrefwindow id=d52903e3636 href="http://www.ncbi.nlm.nih.gov/pubmed/9039207">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3639 href="http://dx.doi.org/10.1016/S0190-9622(97)80405-7">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1016979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e3648 class=n-a></a>Lecuit M, Abachin E, Martin A, <i> et al.</i>: Immunoproliferative small intestinal disease associated with <i>Campylobacter jejuni</i>. <i>N Engl J Med.</i> 2004; <b>350</b>(3): 239–48. <a target=xrefwindow id=d52903e3662 href="http://www.ncbi.nlm.nih.gov/pubmed/14724303">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3666 href="http://dx.doi.org/10.1056/NEJMoa031887">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1016979">F1000 Recommendation</a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d52903e3680 class=n-a></a>Al-Saleem T, Al-Mondhiry H: Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. <i>Blood.</i> 2005; <b>105</b>(6): 2274–80. <a target=xrefwindow id=d52903e3688 href="http://www.ncbi.nlm.nih.gov/pubmed/15542584">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3691 href="http://dx.doi.org/10.1182/blood-2004-07-2755">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d52903e3700 class=n-a></a>Adam P, Czapiewski P, Colak S, <i> et al.</i>: Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe. <i>Br J Haematol.</i> 2014; <b>164</b>(6): 804–10. <a target=xrefwindow id=d52903e3711 href="http://www.ncbi.nlm.nih.gov/pubmed/24372375">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3714 href="http://dx.doi.org/10.1111/bjh.12703">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d52903e3723 class=n-a></a>Pozzato G, Mazzaro C, Crovatto M, <i> et al.</i>: Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. <i>Blood.</i> 1994; <b>84</b>(9): 3047–53. <a target=xrefwindow id=d52903e3734 href="http://www.ncbi.nlm.nih.gov/pubmed/7949176">PubMed Abstract </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d52903e3743 class=n-a></a>Ferri C, Caracciolo F, Zignego AL, <i> et al.</i>: Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. <i>Br J Haematol.</i> 1994; <b>88</b>(2): 392–4. <a target=xrefwindow id=d52903e3754 href="http://www.ncbi.nlm.nih.gov/pubmed/7803287">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3757 href="http://dx.doi.org/10.1111/j.1365-2141.1994.tb05036.x">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d52903e3766 class=n-a></a>Vannata B, Zucca E: Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. <i>Hematology Am Soc Hematol Educ Program.</i> 2014; <b>2014</b>(1): 590–8. <a target=xrefwindow id=d52903e3774 href="http://www.ncbi.nlm.nih.gov/pubmed/25696916">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3777 href="http://dx.doi.org/10.1182/asheducation-2014.1.590">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730210197"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e3786 class=n-a></a>Pozzato G, Mazzaro C, Dal Maso L, <i> et al.</i>: Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. <i>World J Hepatol.</i> 2016; <b>8</b>(2): 107–16. <a target=xrefwindow id=d52903e3797 href="http://www.ncbi.nlm.nih.gov/pubmed/26807206">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3800 href="http://dx.doi.org/10.4254/wjh.v8.i2.107">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3804 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4716526">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730210197">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732006754"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e3818 class=n-a></a>Couronné L, Bachy E, Roulland S, <i> et al.</i>: From hepatitis C virus infection to B-cell lymphoma. <i>Ann Oncol.</i> 2018; <b>29</b>(1): 92–100. <a target=xrefwindow id=d52903e3829 href="http://www.ncbi.nlm.nih.gov/pubmed/29045541">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3832 href="http://dx.doi.org/10.1093/annonc/mdx635">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732006754">F1000 Recommendation</a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d52903e3845 class=n-a></a>Royer B, Cazals-Hatem D, Sibilia J, <i> et al.</i>: Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. <i>Blood.</i> 1997; <b>90</b>(2): 766–75. <a target=xrefwindow id=d52903e3856 href="http://www.ncbi.nlm.nih.gov/pubmed/9226177">PubMed Abstract </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722007866"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e3865 class=n-a></a>Nocturne G, Mariette X: Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. <i>Br J Haematol.</i> 2015; <b>168</b>(3): 317–27. <a target=xrefwindow id=d52903e3873 href="http://www.ncbi.nlm.nih.gov/pubmed/25316606">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3876 href="http://dx.doi.org/10.1111/bjh.13192">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722007866">F1000 Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d52903e3889 class=n-a></a>Hyjek E, Isaacson PG: Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. <i>Hum Pathol.</i> 1988; <b>19</b>(11): 1315–26. <a target=xrefwindow id=d52903e3897 href="http://www.ncbi.nlm.nih.gov/pubmed/3141260">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3900 href="http://dx.doi.org/10.1016/S0046-8177(88)80287-9">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d52903e3909 class=n-a></a>Hsi ED, Singleton TP, Svoboda SM, <i> et al.</i>: Characterization of the lymphoid infiltrate in Hashimoto thyroiditis by immunohistochemistry and polymerase chain reaction for immunoglobulin heavy chain gene rearrangement. <i>Am J Clin Pathol.</i> 1998; <b>110</b>(3): 327–33. <a target=xrefwindow id=d52903e3920 href="http://www.ncbi.nlm.nih.gov/pubmed/9728607">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3923 href="http://dx.doi.org/10.1093/ajcp/110.3.327">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d52903e3932 class=n-a></a>Zintzaras E, Voulgarelis M, Moutsopoulos HM: The risk of lymphoma development in autoimmune diseases: a meta-analysis. <i>Arch Intern Med.</i> 2005; <b>165</b>(20): 2337–44. <a target=xrefwindow id=d52903e3940 href="http://www.ncbi.nlm.nih.gov/pubmed/16287762">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3943 href="http://dx.doi.org/10.1001/archinte.165.20.2337">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d52903e3953 class=n-a></a>Bracci PM, Benavente Y, Turner JJ, <i> et al.</i>: Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. <i>J Natl Cancer Inst Monographs.</i> 2014; <b>2014</b>(48): 52–65. <a target=xrefwindow id=d52903e3964 href="http://www.ncbi.nlm.nih.gov/pubmed/25174026">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3967 href="http://dx.doi.org/10.1093/jncimonographs/lgu011">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3971 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4207869">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d52903e3980 class=n-a></a>Wang SS, Vajdic CM, Linet MS, <i> et al.</i>: Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. <i>Am J Epidemiol.</i> 2015; <b>181</b>(6): 406–21. <a target=xrefwindow id=d52903e3991 href="http://www.ncbi.nlm.nih.gov/pubmed/25713336">PubMed Abstract </a> | <a target=xrefwindow id=d52903e3994 href="http://dx.doi.org/10.1093/aje/kwu290">Publisher Full Text </a> | <a target=xrefwindow id=d52903e3998 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4402340">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d52903e4007 class=n-a></a>Eguchi K: Apoptosis in autoimmune diseases. <i>Intern Med.</i> 2001; <b>40</b>(4): 275–84. <a target=xrefwindow id=d52903e4015 href="http://www.ncbi.nlm.nih.gov/pubmed/11334384">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4018 href="http://dx.doi.org/10.2169/internalmedicine.40.275">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d52903e4027 class=n-a></a>Nakamura H, Kawakami A, Eguchi K: Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome. <i>Transl Res.</i> 2006; <b>148</b>(6): 281–8. <a target=xrefwindow id=d52903e4035 href="http://www.ncbi.nlm.nih.gov/pubmed/17162248">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4038 href="http://dx.doi.org/10.1016/j.trsl.2006.07.003">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d52903e4047 class=n-a></a>Du M, Diss TC, Xu C, <i> et al.</i>: Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. <i>Leukemia.</i> 1996; <b>10</b>(7): 1190–7. <a target=xrefwindow id=d52903e4058 href="http://www.ncbi.nlm.nih.gov/pubmed/8684001">PubMed Abstract </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d52903e4067 class=n-a></a>Spina V, Rossi D: Molecular pathogenesis of splenic and nodal marginal zone lymphoma. <i>Best Pract Res Clin Haematol.</i> 2017; <b>30</b>(1–2): 5–12. <a target=xrefwindow id=d52903e4075 href="http://www.ncbi.nlm.nih.gov/pubmed/28288716">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4078 href="http://dx.doi.org/10.1016/j.beha.2016.09.004">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d52903e4088 class=n-a></a>Algara P, Mateo MS, Sanchez-Beato M, <i> et al.</i>: Analysis of the <i>IgV<sub>H</sub></i> somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. <i>Blood.</i> 2002; <b>99</b>(4): 1299–304. <a target=xrefwindow id=d52903e4104 href="http://www.ncbi.nlm.nih.gov/pubmed/11830479">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4108 href="http://dx.doi.org/10.1182/blood.V99.4.1299">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d52903e4117 class=n-a></a>Bertoni F, Cazzaniga G, Bosshard G, <i> et al.</i>: Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. <i>Br J Haematol.</i> 1997; <b>97</b>(4): 830–6. <a target=xrefwindow id=d52903e4128 href="http://www.ncbi.nlm.nih.gov/pubmed/9217184">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4131 href="http://dx.doi.org/10.1046/j.1365-2141.1997.1392954.x">Publisher Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d52903e4140 class=n-a></a>Conconi A, Bertoni F, Pedrinis E, <i> et al.</i>: Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. <i>Blood.</i> 2001; <b>98</b>(3): 781–6. <a target=xrefwindow id=d52903e4151 href="http://www.ncbi.nlm.nih.gov/pubmed/11468179">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4154 href="http://dx.doi.org/10.1182/blood.V98.3.781">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d52903e4163 class=n-a></a>Rinaldi A, Forconi F, Arcaini L, <i> et al.</i>: Immunogenetics features and genomic lesions in splenic marginal zone lymphoma. <i>Br J Haematol.</i> 2010; <b>151</b>(5): 435–9. <a target=xrefwindow id=d52903e4174 href="http://www.ncbi.nlm.nih.gov/pubmed/21113978">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4177 href="http://dx.doi.org/10.1111/j.1365-2141.2010.08347.x">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d52903e4186 class=n-a></a>Bertoni F, Conconi A, Capella C, <i> et al.</i>: Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. <i>Blood.</i> 2002; <b>99</b>(7): 2541–4. <a target=xrefwindow id=d52903e4197 href="http://www.ncbi.nlm.nih.gov/pubmed/11895791">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4200 href="http://dx.doi.org/10.1182/blood.V99.7.2541">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d52903e4209 class=n-a></a>Tierens A, Delabie J, Pittaluga S, <i> et al.</i>: Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. <i>Blood.</i> 1998; <b>91</b>(7): 2381–6. <a target=xrefwindow id=d52903e4220 href="http://www.ncbi.nlm.nih.gov/pubmed/9516137">PubMed Abstract </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d52903e4230 class=n-a></a>Thieblemont C, Bertoni F, Copie-Bergman C, <i> et al.</i>: Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. <i>Semin Cancer Biol.</i> 2014; <b>24</b>: 33–42. <a target=xrefwindow id=d52903e4241 href="http://www.ncbi.nlm.nih.gov/pubmed/24333758">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4244 href="http://dx.doi.org/10.1016/j.semcancer.2013.11.005">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d52903e4253 class=n-a></a>Zibellini S, Capello D, Forconi F, <i> et al.</i>: Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. <i>Haematologica.</i> 2010; <b>95</b>(10): 1792–6. <a target=xrefwindow id=d52903e4264 href="http://www.ncbi.nlm.nih.gov/pubmed/20511668">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4267 href="http://dx.doi.org/10.3324/haematol.2010.025437">Publisher Full Text </a> | <a target=xrefwindow id=d52903e4271 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2948108">Free Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726000669"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d52903e4280 class=n-a></a>Bikos V, Karypidou M, Stalika E, <i> et al.</i>: An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors. <i>Clin Cancer Res.</i> 2016; <b>22</b>(8): 2032–40. <a target=xrefwindow id=d52903e4291 href="http://www.ncbi.nlm.nih.gov/pubmed/26647217">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4294 href="http://dx.doi.org/10.1158/1078-0432.CCR-15-1170">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726000669">F1000 Recommendation</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d52903e4307 class=n-a></a>Bikos V, Darzentas N, Hadzidimitriou A, <i> et al.</i>: Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. <i>Leukemia.</i> 2012; <b>26</b>(7): 1638–46. <a target=xrefwindow id=d52903e4318 href="http://www.ncbi.nlm.nih.gov/pubmed/22222599">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4321 href="http://dx.doi.org/10.1038/leu.2012.3">Publisher Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d52903e4330 class=n-a></a>Warsame AA, Aasheim HC, Nustad K, <i> et al.</i>: Splenic marginal zone lymphoma with <i>VH1-02</i> gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity. <i>Blood.</i> 2011; <b>118</b>(12): 3331–9. <a target=xrefwindow id=d52903e4344 href="http://www.ncbi.nlm.nih.gov/pubmed/21725051">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4348 href="http://dx.doi.org/10.1182/blood-2011-03-341651">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d52903e4357 class=n-a></a>Traverse-Glehen A, Davi F, Ben Simon E, <i> et al.</i>: Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. <i>Haematologica.</i> 2005; <b>90</b>(4): 470–8. <a target=xrefwindow id=d52903e4368 href="http://www.ncbi.nlm.nih.gov/pubmed/15820942">PubMed Abstract </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d52903e4378 class=n-a></a>van den Brand M, van Krieken JH: Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. <i>Haematologica.</i> 2013; <b>98</b>(7): 1003–13. <a target=xrefwindow id=d52903e4386 href="http://www.ncbi.nlm.nih.gov/pubmed/23813646">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4389 href="http://dx.doi.org/10.3324/haematol.2012.083386">Publisher Full Text </a> | <a target=xrefwindow id=d52903e4392 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3696602">Free Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d52903e4401 class=n-a></a>Marasca R, Vaccari P, Luppi M, <i> et al.</i>: Immunoglobulin gene mutations and frequent use of <i>VH1-69</i> and <i>VH4-34</i> segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. <i>Am J Pathol.</i> 2001; <b>159</b>(1): 253–61. <a target=xrefwindow id=d52903e4419 href="http://www.ncbi.nlm.nih.gov/pubmed/11438472">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4422 href="http://dx.doi.org/10.1016/S0002-9440(10)61691-4">Publisher Full Text </a> | <a target=xrefwindow id=d52903e4425 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1850410">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d52903e4434 class=n-a></a>Craig VJ, Arnold I, Gerke C, <i> et al.</i>: Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. <i>Blood.</i> 2010; <b>115</b>(3): 581–91. <a target=xrefwindow id=d52903e4445 href="http://www.ncbi.nlm.nih.gov/pubmed/19965661">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4448 href="http://dx.doi.org/10.1182/blood-2009-06-228015">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d52903e4457 class=n-a></a>Lenze D, Berg E, Volkmer-Engert R, <i> et al.</i>: Influence of antigen on the development of MALT lymphoma. <i>Blood.</i> 2006; <b>107</b>(3): 1141–8. <a target=xrefwindow id=d52903e4468 href="http://www.ncbi.nlm.nih.gov/pubmed/16204314">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4471 href="http://dx.doi.org/10.1182/blood-2005-04-1722">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d52903e4480 class=n-a></a>Greiner A, Knörr C, Qin Y, <i> et al.</i>: CD40 ligand and autoantigen are involved in the pathogenesis of low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. <i>Dev Immunol.</i> 1998; <b>6</b>(3–4): 187–95. <a target=xrefwindow id=d52903e4491 href="http://www.ncbi.nlm.nih.gov/pubmed/9814592">PubMed Abstract </a> | <a target=xrefwindow id=d52903e4494 href="http://dx.doi.org/10.1155/1998/18679">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Mar 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-406&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-406&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Universit&agrave; della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland<br/> <sup>2</sup> Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland<br/> <p> <div class=margin-bottom> Francesco Bertoni <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Davide Rossi <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Emanuele Zucca <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-406/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 28 Mar 2018, 7:406 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.13826.1">https://doi.org/10.12688/f1000research.13826.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Bertoni F <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15029 data-id=13826 data-downloads="" data-views="" data-scholar="10.12688/f1000research.13826.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-406/v1/pdf?article_uuid=8d302fa9-aa7f-443e-9cd3-1f97e800d9ae" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.13826.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Bertoni F, Rossi D and Zucca E. Recent advances in understanding the biology of marginal zone lymphoma [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):406 (<a href="https://doi.org/10.12688/f1000research.13826.1" target=_blank>https://doi.org/10.12688/f1000research.13826.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=13826 id=mobile-track-article-signin-13826 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/13826?target=/articles/7-406"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15029 /> <input name=articleId type=hidden value=13826 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Lugui Qiu</strong>, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, China </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Theodoros P Vassilakopoulos</strong>, Department of Haematology, National and Kapodistrian University, Laikon General Hospital, Greece </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Mar 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-406&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-406&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=32077-32181></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=32074-32182></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-406/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>28 Mar 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lugui Qiu</strong>, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, China </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Theodoros P Vassilakopoulos</strong>, Department of Haematology, National and Kapodistrian University, Laikon General Hospital, Greece </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-406&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-406/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding the biology...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-406/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-406/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-406/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Bertoni F et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-406/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-406",
            templates : {
                twitter : "Recent advances in understanding the biology of marginal zone.... Bertoni F et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-406/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding the biology of marginal zone lymphoma", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding the biology of marginal zone lymphoma", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/13826/15029")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15029");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "32181": 0,
                           "32182": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "975cd628-65da-4239-925f-65b0bd9e5f0a";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-406.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-406.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-406.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-406.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-406.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>